105 related articles for article (PubMed ID: 19243496)
1. Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
Kim SJ; Kim JH; Sun JM; Kim MG; Oh JW
J Viral Hepat; 2009 Oct; 16(10):697-704. PubMed ID: 19243496
[TBL] [Abstract][Full Text] [Related]
2. Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation.
Kim MG; Moon JS; Kim EJ; Lee SH; Oh JW
Biochem Biophys Res Commun; 2012 Apr; 421(1):112-8. PubMed ID: 22490666
[TBL] [Abstract][Full Text] [Related]
3. HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice.
Lee SH; Moon JS; Pak BY; Kim GW; Lee W; Cho H; Kim S; Kim SJ; Oh JW
Sci Rep; 2018 Aug; 8(1):12469. PubMed ID: 30127498
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
[TBL] [Abstract][Full Text] [Related]
5. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
8. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
9. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons.
Hamazaki H; Ujino S; Miyano-Kurosaki N; Shimotohno K; Takaku H
Biochem Biophys Res Commun; 2006 May; 343(3):988-94. PubMed ID: 16566896
[TBL] [Abstract][Full Text] [Related]
11. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
12. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
[TBL] [Abstract][Full Text] [Related]
13. Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.
Chang KO; George DW
J Virol; 2007 Sep; 81(18):9633-40. PubMed ID: 17609266
[TBL] [Abstract][Full Text] [Related]
14. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
15. Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
Escuret V; Martin A; Durantel D; Parent R; Hantz O; Trépo C; Menguy T; Bottius E; Dardy J; Maral J; Escary JL; Zoulim F
Antimicrob Agents Chemother; 2006 Dec; 50(12):3984-91. PubMed ID: 17030563
[TBL] [Abstract][Full Text] [Related]
16. Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus.
Zhao LJ; Wang W; Wang WB; Ren H; Qi ZT
Cytokine; 2015 Mar; 72(1):17-24. PubMed ID: 25544181
[TBL] [Abstract][Full Text] [Related]
17. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
